Institutions Holding Call Options on Regeneron Pharmaceuticals, Inc. (REGN)
This table provides information about the call option holders of Regeneron Pharmaceuticals, Inc. (REGN). We have compiled data on the institutions that hold call options on the stock, with a total of 1.39 Million call options outstanding, which have been reported (via 13F filing form) to have a value of $783 Million at the end of the reported quarter. These call option holders have the right, but not the obligation, to buy AAPL shares at a specified price within a certain time frame.
Holding | Report Date | calls Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Hudson Bay Capital Management LP
Greenwich, CT |
May 14, 2025 Q1 2025 |
3,100
calls
|
$1.75 Million
0.01% of portfolio
|
N/A
|
|
Eisler Capital Management Ltd.
London, X0 |
May 14, 2025 Q1 2025 |
2,700
calls
|
$1.52 Million
0.01% of portfolio
|
N/A
|
|
Point72 (Difc) LTD
Dubai, C0 |
May 15, 2025 Q1 2025 |
1,800
calls
|
$1.02 Million
0.05% of portfolio
|
N/A
|
|
Citigroup Inc
|
May 12, 2025 Q1 2025 |
1,800
calls
|
$1.02 Million
0.0% of portfolio
|
N/A
|
|
Arrowpoint Investment Partners (Singapore) Pte. Ltd.
Singapore, U0 |
May 12, 2025 Q1 2025 |
1,400
calls
|
$790,496
0.11% of portfolio
|
N/A
|
|
Hsbc Holdings PLC
London, X0 |
May 14, 2025 Q1 2025 |
1,200
calls
|
$677,568
0.0% of portfolio
|
Q1 2025
Reduced 90.7%
|
|
Capstone Investment Advisors, LLC
New York, NY |
May 15, 2025 Q1 2025 |
500
calls
|
$282,320
0.0% of portfolio
|
Q1 2025
Reduced 80.0%
|
|
High Tower Advisors, LLC
Chicago, IL |
May 12, 2025 Q1 2025 |
200
calls
|
$112,928
0.0% of portfolio
|
Q1 2025
New holding
|